文献速递神经创伤神经重症

依那普利与普萘洛尔对孤立性重型创伤性脑损伤后神经功能恢复的疗效与安全性:一项随机临床试验

Efficacy and Safety of Enalapril and Propranolol on Neurologic Recovery After Isolated Severe Traumatic Brain Injury: A Randomized Clinical Trial.
PubMed 文献 · World Neurosurg · 2025-05-20

这项单盲随机临床试验在2所大学医院纳入140例年龄>18岁的孤立性重型TBI患者,分为普萘洛尔组、依那普利组、联合组和无用药组,以GOS-E为主要结局。多因素回归显示出院GCS与GOS-E直接相关,普萘洛尔组出院GCS更优;作者认为依那普利和普萘洛尔单用或联用均有效且安全,普萘洛尔在随访期GOS-E方面更有前景。

要点

  • 140例重型孤立性TBI患者随机分为普萘洛尔、依那普利、联合及无用药4组。

核心结论

  • 作者认为,依那普利和普萘洛尔单用及联用对重型孤立性TBI后的神经功能恢复及其他结局均有效且安全。
  • 就长期结局而言,普萘洛尔在随访期GOS-E方面显示出更有前景的结果。

研究设计与样本

  • 单盲随机临床试验,于2020年至2021年在2所大学医院开展。
  • 纳入年龄>18岁、经监护人合法知情同意的孤立性重型TBI患者,最终分析140例。
  • 分为G1普萘洛尔组、G2依那普利组、G3普萘洛尔+依那普利组和G4无用药组;主要结局为GOS-E。
  • 次要结局包括言语失用评定量表、心血管稳定性、死亡率、呼吸机依赖和住院时间;P≤0.05为显著。

主要发现

  • 患者平均年龄36.91±16.19岁,GCS评分中位数5分;4组基线生命体征和TBI严重程度指数分布均衡(P>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It has been hypothesized that propranolol and enalapril can provide cardiovascular stability without any negative impact on neurologic recovery after severe traumatic brain injury (TBI). Although propranolol and enalapril have been proposed to have beneficial effects as cardiovascular stabilizers in TBI, many neurologic effects remain obscure. We hypothesized which of the following drugs could improve The Glasgow Outcome Scale-extended (GOS-E) in severe TBI patients. METHODS: This single-blinded randomized, clinical trial was conducted in 2 university hospitals from 2020 to 2021. All the patients age >18 years with severe isolated TBI who had legal consent to participate (by guardians) were enrolled. G1 (propranolol), G2 (enalapril), G3 (propranolol + enalapril), and G4 (no medication) were defined. The GOS-E was the primary outcome. Secondary outcomes included the Apraxia of Speech Rating Scale, cardiovascular stability, mortality rate, ventilator dependency, and hospital length of stay. P ≤ 0.05 was defined as significant. RESULTS: One hundred and forty patients were reviewed in the final analysis. The mean patient age was 36.91 ± 16.19 years, and the median Glasgow Coma Scale (GCS) score was 5. Baseline vital signs and TBI severity indices were distributed equally among the 4 groups (P > 0.05). Multivariate regression analysis showed that GOS-E was directly associated with discharge GCS in all groups (P < 0.001, β = 0.199, 0.16 ≤ confidence interval [CI] ≤ 0.22). Multivariate regression analysis showed better on-discharge GCS in G1 (P < 0.001; β = 2.26; 0.58 ≤ CI ≤ 3.9). CONCLUSION: Regarding neurologic recovery and other outcomes, enalapril and propranolol, both alone and in combination, are effective and safe after severe isolated TBI. Considering long-term outcomes, propranolol showed more promising results in GOS-E during the follow-up period.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Mahmoodkhani M, Sahraei A, Shafiei M, et al. Efficacy and Safety of Enalapril and Propranolol on Neurologic Recovery After Isolated Severe Traumatic Brain Injury: A Randomized Clinical Trial. World Neurosurg. 2025. PMID: 40404011. doi:10.1016/j.wneu.2025.124078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。